Securities Code: 300199 Securities Abbreviation: Han's Pharmaceutical Announcement No.: 2026-033
Shenzhen Han's Pharmaceutical Co., Ltd.
Announcement on Approval of Listing Application for Linaclotide API by Wholly-Owned Subsidiary
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
On June 21, 2026, Shenzhen Han's Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") received the "Chemical API Listing Application Approval Notice" issued by the National Medical Products Administration from its wholly-owned subsidiary, Han's Pharmaceutical (Wuhan) Co., Ltd. The relevant situation is hereby announced as follows: